SPC365

Predictors of LV reverse remodeling after SAVR: insights from a prospective TTE and CMR study in patients with severe aortic stenosis.

Session: Comunicações Orais - Sessão 10 - Imagem em Cardiologia
Speaker: Rita Reis Santos

Congress: CPC 2024
Topic: B. Imaging
Theme: 03. Imaging
Subtheme: 03.6 Cross-Modality and Multi-Modality Imaging Topics
Session Type: Comunicações Orais
FP Number: ---
Authors: Rita Reis Santos; João Abecasis; Sérgio Maltês; Pedro Lopes; Sara Guerreiro; Pedro Freitas; António Ferreira; Regina Ribeiras; Victor Gil; Nuno Cardim; Pedro Adragão; José Pedro Neves

<p style="text-align:center"><span style="font-family:Arial,Helvetica,sans-serif"><span style="font-size:11pt"><span style="color:#000000"><strong><span style="font-size:12pt"><span style="color:black">Background: </span></span></strong><span style="font-size:12pt"><span style="color:black">Left ventricular (LV) remodeling in patients with severe aortic stenosis (AS) is believed to be reversible after pressure overload relieve, as provided by both surgical (SAVR) or transcatheter aortic valve replacement. However, LV reverse remodeling (RR) is far from uniform in patients with AS and the same clinical indication for treatment.</span></span></span></span></span></p>

<p style="text-align:center"><span style="font-family:Arial,Helvetica,sans-serif"><span style="font-size:11pt"><span style="color:#000000"><strong><span style="font-size:12pt"><span style="color:black">Aim: </span></span></strong><span style="font-size:12pt"><span style="color:black">To determine the prevalence and imaging predictors of LV RR after SAVR in patients with severe symptomatic AS.</span></span></span></span></span></p>

<p style="text-align:center"><strong><span style="font-size:12pt"><span style="color:black">Methods</span></span></strong><span style="color:black; font-family:Arial,Helvetica,sans-serif; font-size:12pt">: single-center, prospective cohort study enrolling 119 patients with severe symptomatic AS (age 71&plusmn;8y, 49% male; mean transaortic gradient 62&plusmn;18mmHg, mean indexed aortic valve area (AVAi) 0.40&plusmn;0.10 cm<sup>2</sup>/m<sup>2</sup>, mean LV ejection fraction by TTE 58&plusmn;9%), with no previous history of ischemic cardiomyopathy, undergoing SAVR between 2019 and 2022. All patients underwent serial imaging assessment beyond clinical characterization (transthoracic echocardiogram &ndash; TTE, and 1.5T cardiac magnetic resonance - CMR) prior to surgery and at the 3<sup>rd</sup> to 6<sup>th</sup> month post-SAVR. Endomyocardial biopsy (EMB) for myocardial fibrosis quantification (<em>Masson&acute;s Trichrome</em> histochemistry) was performed during SAVR. &nbsp;LV RR was defined when in presence of at least one of the imaging criteria: </span>&gt;&nbsp;<span style="font-family:Arial,Helvetica,sans-serif"><span style="font-size:11pt"><span style="color:#000000"><span style="font-size:12pt"><span style="color:black">15% reduction in LV end-diastolic indexed volume (LVEDV) by CMR; &gt;&nbsp;</span></span><span style="font-size:12pt"><span style="color:black">15% reduction in LV indexed mass (LVM) by CMR; &gt;&nbsp;</span></span><span style="font-size:12pt"><span style="color:black">15% reduction in LV geometric remodeling by CMR; &gt;</span></span><span style="font-size:12pt"><span style="color:black">10% increase in LV ejection fraction (LVEF) either from TTE or CMR; &gt;&nbsp;</span></span><span style="font-size:12pt"><span style="color:black">50% increase in global longitudinal strain (GLS) at TTE. Clinical, imaging and histology derived data were compared in patients with post-SAVR LV RR and for each of the defined criteria.</span></span></span></span></span></p>

<p style="text-align:center"><span style="font-family:Arial,Helvetica,sans-serif"><span style="font-size:11pt"><span style="color:#000000"><strong><span style="font-size:12pt"><span style="color:black">Results</span></span></strong><span style="font-size:12pt"><span style="color:black">: 107 patients (90%) met at least one criteria of LV RR. Morphological criteria were more prevalent than LV functional improvement after SAVR (Figure 1). In patients who met at least one criteria of LV RR, no differences were found between NT-proBNP, LV tissue characterization (by CMR) or myocardial fibrosis at EMB. Yet, those with LV RR had significantly smaller preoperative AVAi (0.4&plusmn;0.9 vs 0.5&plusmn;0.9 cm<sup>2</sup>/m<sup>2</sup>, p=0.007) and higher mean valvular gradients (62&plusmn;18 vs 49&plusmn;12 mmHg, p=0.017). Considering individual LV RR criteria, patients with higher NT-proBNP levels met LVEF and morphological (LVEDV and LVM) LV RR criteria (p=0.027, p=0.016 and p= 0.003, respectively). Patients with higher % of late gadolinium enhancement on pre-operative CMR [7.8 (IQR 2.5-11.3) vs. 1.6 (IQR 0-5.2)%, p=0.017] had significant GLS improvement after SAVR.</span></span></span></span></span></p>

<p style="text-align:center"><span style="font-family:Arial,Helvetica,sans-serif"><span style="font-size:11pt"><span style="background-color:white"><span style="color:#000000"><strong><span style="font-size:12pt"><span style="color:black">Conclusion</span></span></strong><span style="font-size:12pt"><span style="color:black">: In a cohort of patients with classical severe, symptomatic AS, </span></span><span style="font-size:12pt"><span style="color:#222222">LV RR is common after SAVR, occurring in almost 9 out of every 10 patients. Both indexes of worse valve narrowing and pre-operative LV adaptation are associated with favorable RR after surgery. This underlines the benefits of a timely intervention even in patients with more advanced disease.</span></span></span></span></span></span></p>